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Some Comments on Potency Measures in
Mutagenicity Research
by Barry H. Margolin,' ByungSoo Kim,2 Melissa G.
Smith,' Bethel A. Fetterman,V WalterW. Piegorsch,3
and Errol Zeiger4
In this article, the measurement ofthe potency ofachemical ormixture from itsdose response in a particularassay
isaddressed. Attention is focused on data from the Ames Salmonella assay. Three measuresofpotency areexplored
and shown to be highlycorrelated. The presentation then discusses specific areasofresearch that might benefit from
a study ofpotency.
Introduction
For morethan adecade, theNationalInstituteofEnvironmen-
tal Health Sciences (NIEHS) has beendeveloping an extensive
multitest genetic toxicology database. The mostnotable feature
ofthis database is a set of results from the application offour
commonly used in vitroshort-term tests(STTs) to 114chemicals
for which National Toxicology Program (NTP) 2-year rodent
carcinogenicity assay data are available. The four STTs are
mutagenesis in Salmonella (SAL) and mouse lymphoma cells
(MLA) andchromosomeaberrations (ABS)andsisterchromatid
exchanges (SCE) in Chinese hamster ovary cells. The first ma-
joranalyses performed onthisdatabasefocused on73chemicals
whosetestingforcarcinogenicitybytheNTP wascompleteddur-
ing the period December 1976 to January 1985 (1). These
analyses focusedprimarily onthequalitativepredictivity ofro-
dentcarcinogenicity fromthefourin vitroSTTs. Themajor con-
clusions ofthat study were: a) Qualitative concordances ofthe
four STTs with rodentcarcinogenicity did not show significant
differences among assays (all approximately 60%) and were
much lowerthanprevious estimates. b) AnegativeSTT was not
predictive ofnoncarcinogenicity; a positive SAL, on the other
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hand, was somewhatpredictiveofcarcinogenicity, butpositives
intheotherthreetestswerelessso. c)Therewasnocomplemen-
tarity amongtheSTTs, andnobatteryoftestsconstructed from
two or moreofthese four STTs improved upon the carcinogen
predictivity ofthe SAL test alone.
Theseconclusionselicitedvariedreactionswithinthegenetic
toxicology community. Some individuals felt there must be
something erroneous in the findings; after all, during the
previousdecadetherehadbeennumerouspublicationsreporting
concordancesof90% orbetterforSAL. Twocriticismsdidap-
pear worthy offurther investigation. The first was that the 73
chemicals intheinitial investigation wereinsomewayatypical,
andthereforereplicationofthefindings wasneededfroma sec-
ond set ofchemicals. The second criticism was that statistical
analyses had primarily focused on the qualitative (positive/
negative) results obtained for the 73 chemicals, and that an
analysis that included quantitative results, e.g., measures of
potency, mightleadtodifferentconclusions regardingthepredic-
tivity ofrodentcarcinogenicity from STTs.
Thefirstcriticismwaseffectively answeredbythepublication
oftheresultsofafollow-up studyofanadditional41 chemicals
theNTPhadtestedforbothrodentcarcinogenicity andgenetic
toxicityusingthefourSTh listedabove(2,3). Thesepaperscon-
firmedthemajorconclusionsdrawnbyTennantetal. (I)regard-
ing the lackofcomplementarity among the four STTs and the
inability ofabattery drawn from these four assays to improve
upontheSalmonellaassay forpredicting rodentcarcinogenici-
ty. Interestingly, theinitial73-chemicalstudyandthe41-chemical
follow-up demonstrated no statistically significant differences
between the two data sets on any relevant dimension. Conse-
quently, asitservesthepurposesofthispaper, the73-chemical
and41-chemicaldatasetswillbetreatedeitherasaninitial study
and a replicate or as onecombined study of 114 chemicals; the
formerwillpermitexploratoryanalysesofthe73-chemicaldataMARGOLINETAL.
remaining observations on dose yields the measure of
mutagenic potency, which is labeledbB. Computer code to
evaluatethis measurewasgraciouslyprovidedbyBernstein
etal. (4).
2. Margolinetal. (5)describeanestimateofmutagenicpotency
thatisbasedon aclassofnonlineardose-responsemodels
oftheAmesassay. Themodelsdescribetheprobabilityp(D)
thataplatedbacteriumwillgiverisetoavisiblerevertantcol-
ony, giventhattheplateonwhichitwasplacedwasexposed
todose D ofthetestchemical:
g/c ---~ ~ p(D) = (1- exp[-(a + OD)])-T(D) .
I_, Here T(D) is the function describing the toxicity to the
0.0 0 0.4 0.6 0.8 1.0 bacteriumofdoseDofthetestchemical.Thetwoformsfor
Dose T(D) considered were:
FIGURE 1. Threetheoretical dose-response curves, all intersecting at a com-
mon high dose. The question: which is the most potent ofthe three?
set, withthe41-chemicaldata setreservedfor purposesofvalida-
tion ofany important findings.
Measures of Potency
The second criticism discussed above, that use ofquantitative
information would improve carcinogenicity predictivity ofthe
fourin vitroSTTs, wasstillunanswered. Itfocusedattention on
the need for the development and evaluation of measures of
potency for each ofthe four STTs involved inthe NTP studies.
Onreflection, itisclearthatthereis nouniqueanduniversal way
to measurethepotencyofachemical in an assayunlessalldose-
response curves forthat assay sharethe sameshape, e.g., linear.
If the shapes ofdose-response curves vary from chemical to
chemical, as they do in the real world, then the selection of a
measureofpotency tocharacterize anobserveddose-response
curve is not astraightforward matter. Considerthethreedose-
response curvespicturedinFigure 1. Which is the mostpotent
ofthethree?Giventhatthe purposeofthis lineofresearch is to
addressproblems ofhumanhealth, theargumentmightbemade
thatbehavior atlowdoses, the most commonhuman exposure,
should be used formeasuring potency. Ideallythen, onewould
want toknowtheincrementalchangein, andhencethederivative
of, thedose-response curve atlowdose. Althoughthisargument
is attractive, it may be fallacious for purposes ofpredicting ro-
dentcarcinogenicity. In the work tobedescribed, as well as in
ongoing work, various measures ofpotency areconsidered.
This paperis aninterimreport onthedevelopmentandevalua-
tionofpotency measuresforeachofthefourSTTsandtheinter-
relations ofthese measures. Initial efforts have focused on the
SAL assay, forwhichproposals formeasuring thepotency ofthe
response observed havebeenpublished (4,5). Three measures
ofpotency have been considered initially:
1. The point-rejection estimate of Bernstein et al. (4) is
predicated on anassumptionoflow-doselinearityofthedose
response. Inthe computation ofthisestimate, observations
thatdepartfromtheassumedlinearity arediscarded inturn
from the highest dose to the lowest, with the slope recom-
puted after each discard. The slope ofthe regression ofthe
T(D) = exp(-yD)
or
T(D) = [2- exp(yD)]+
where [x]+=max(x, 0). In this model of the SAL assay
response, the parameter reflects themutagenic effect per
unitdose, adjustedforconcomitanttoxicity. Theestimateof
presented in Margolin etal. (5) is denoted by bm.
3. The maximum observed slope is defined as the maximum
averagecolony count perplate perdoseachievedat anyofthe
positivedoses in anexperiment. IfYkisthe meannumberof
revertants perplateobserved atdoseDk, for 0= Do < D 1
< ... <Dr, for rpositivedoses, theestimate isgivenby:
maxk [(Yk -Yo)/(Dk - DO)]
This estimate ofpotency is denotedby bx.
Thefirsttwo potency measuresabove arespecific totheSAL
assay because they attempt to estimate low-dose mutagenic
potency after adjustment for toxicity. As mentioned, the argu-
mentforthisfocus onlowdoseisthatit morenearlyreflectsthe
typicalhumanexposure. Thethirdmethodofestimatingpotency
isgenericanddirectlyapplicabletoeachofthefourSTTsunder
study. This reportwillbrieflydiscussthebehaviorofthesethree
measures of potency for the SAL assay. Three other generic
measuresofpotencyapplicable todose-response curvesfromall
assays are also under study but they will not be reported here.
These generic measures are:
4. The simple slope obtained by a linear regression of the
observedSALcolonycount/plate onthedose, ignoring con-
siderations of nonlinearity due to toxicity and other
phenomena. This estimate is denoted by bL.
5. The lowest effective dose (LED), i.e., the lowest dose
yielding an effect that is statistically significantly elevated
over the control value. In the particular implementation
studied, adjustmentismadeformultiplecomparisons. In us-
ingthis measure, itistacitlyacknowledgedthatoneis a cap-
tive ofthe doses that are used in theexperiment, i.e., this
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FIGURE 2. Plot oflog(l+bB) versus log(l+bm).
measure can only assume values equal to one of the doses
employed.
6. The measure ofpotency ofMargolin and Risko (6), which
estimates thedose needed toinduce a "unit" increase (DUI)
over control for a dose response that is assumed to be a
second-degree polynomial. By definition, this measure is
arbitrary in its definition of a unit increase. Nevertheless,
within any one assay, it produces a credible measure of
relative potency.
Descriptive Statisticsforthe Potency
Measures bB, bM, and bx
For the 73-chemical data set, there are 2613 experiments
available for evaluation ofbB, bM, and bX, whereas for the
41-chemical data set there are 1464. The estimator bX is
alwaysdefined, aslong asthereis onetreateddoseand a con-
trol. Thisis notthe caseforbBorbM. FortheevaluationofbB,
atleasttwotreateddoses mustremainafterexclusion, inturn,
ofthehighdosesthatdeparted fromlinearity ofthe response.
For the estimation ofbM, there mustbe at least two treated
dosesavailable forfittingthenonlinearmodelafterexclusion
of high doses that exhibit very substantial toxicity; for
elaborationofthispoint, seeMargolinetal. (7). Although it
isclearthattheselasttwo measuresofpotency maynotalways
becomputable, theresultsbelow onpercentagecomputability
ofthe measures forthe NTPdata are surprising with regard
tobB(Table 1).
hkble 1. Percent ofexperimentsforwhich measure iscomputable.
Data set bB bM bx
73 chemicals 77 94 100
41 chemicals 77 94 100
Thus,BBcannotbecomputedfor23% ofeitherdatabase, a sur-
prisingly high percentage.
Foreachofthethree measuresofpotency, thedistributionof
estimated chemical potencies across the database is highly
skewed. Logging the three potency measures yields better-
behaved random variables that are much less skewed. Further
evidence forthisclaim forloggingthe measures canbe seen in
thecorrelationmatrixes forthethree measures, withandwithout
logging. For the unlogged measures, the observed correlation
matrix is shown in Table 2. The correlation matrix for logged
measures is shown in Table 3.
Table2. Correlation matrixfor unlogged measures.
bB bM bx
bB 1.00 0.74 0.78
bm 1.00 0.81
bx 1.00
Table3. Correlation matrixforlogged measures.
bB bM bx
bB 1.00 0.95 0.94
bM 1.00 0.90
bx 1.00
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Figure2 isascatterplotoflog (1+bB) versuslog(l+bM) show-
ing the strong linear relationship between thetwo. This strong
correlationisreassuringbecausebothmeasuresstrivetoestimate
theslopeofthesamedose-response curveatlowdose. Forsitua-
tions in which one ofthese two measures has been used in an
evaluation, suchasinPiegorschandHoel(8), onewouldnotex-
pect much change iftheother measure were substituted.
Uses of Measures of Potency
Thestudyofmeasuresofpotencywasinitiallymotivatedbythe
desire to predict rodent carcinogenicity from quantitative
measuresofmutagenicity, i.e., mutagenicpotencyofchemicals
forindividualassays orforabatteryofassays. Thiscanandwill
be studied either with carcinogenicity itself remaining a
qualitative variable or with carcinogenicity being treated in a
quantitative manneraswell. Aspecificapplicationoftheformer
wouldbeanextensionoftheCarcinogenicity PredictionBattery
Selection (CPBS)* methodologyofRosenkranz etal. (9) toin-
cludemeasuresofpotencyofshort-termassays. Foradiscussion
ofoneextensiontoincludedependent,qualitativevariables, plus
alistofassociated references forCPBS, seeKimand Margolin
(10).
Anotherpossible useofameasureofmutagenic potency oc-
curs in certain epidemiological studies, where urines of in-
dividual subjects aretestedviatheSalmonellaassayforsignsof
exposuretoenvironmental toxicants (11). Anexamplewouldbe
thestudy ofoncology nurses whoareresponsiblefordelivering
antineoplastic treatments (12). Ifmultiple concentrations ofa
subject'surinearetestedinthisassay, adose-response curveis
obtained. Ameasure ofpotency fromthedose-response curve
wouldfacilitateanalysesmoresophisticatedthansimply recor-
ding whether a response at least two times background was
observed, and then proceeding to analyze this dichotomous
variable. Onecouldanticipategreaterstudypowerderiving from
theuseofapotencymeasure, whichinturnwouldpermittheuse
ofsmaller study sample sizes.
Anotheruseofmeasuresofmutagenicpotencywillbetoassess
the potencies observed forthe chemicals tested intheongoing
NTP "Sea ofMutagens" study. In this study, a representative
sampleof100chemicalshasbeendrawnfromtheapproximately
50,000 synthetic chemicals introduced to commerce inthe last
45years. Althoughitisnotfeasibletotestinatimelyfashioneach
ofthe 100 chemicals in a2-year rodent carcinogenicity assay,
each can betested for mutagenicity using Salmonella. Results
fromthisstudywilladdressthequestionofwhetherthehuman
raceisawashinaseaofmutagensofitsowncreation. Theuseof
ameasureofpotencyinthisNTPstudywillpermitarefinement
oftheobjectiveinwhichnotallmutagenswillbetreatedequal-
ly. Ifa certain percentage ofthe 100 chemicals is found to be
positive, itwillbemostinformativetoknowthedistributionof
thepotencies forthepositives.
Finally, studying the distribution ofpotencies in the NTP
databasewillshedlightonthereasonfortheobservationamong
NTPtoxicologists that incertain STTs, positive results are not
alwaysreproducible. IfoneassumesthattheanalysisofanSTT
doesnothaveaninherently elevatedfalsepositive level, thema-
jorfactorcontrolling thereproducibility ofapositive response
isthepoweroftheassaytodetectaneffect. Thispowerwill vary
fromchemicaltochemical. Withtheuseofameasureofpotency
foraparticularSTT, onecanformulateanapproximatedistribu-
tion ofpowerforthe chemicals in one's database and then pro-
ceed to investigate the probability of reproducing an initial
positive response for the chemicals in question. Intuitively,
stronglyactingchemicalswillhavehighpowerandahigh level
ofreproducibility, whereas weakly acting agents will have low
powerand lowreproducibility. Theuseofameasureofpotency
will enableonetoquantify inprobabilistic termsthis important
issue oftest result reproducibility.
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